Literature DB >> 2612079

Reversible dilated cardiomyopathy induced by methamphetamine.

L J Jacobs1.   

Abstract

This brief report details the case of a woman who was thought, after extensive evaluation, to have idiopathic congestive cardiomyopathy. It was subsequently found that systolic ventricular dysfunction was due to amphetamine abuse, and that ventricular function normalized after discontinuation of this drug.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2612079     DOI： 10.1002/clc.4960121211

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN： 0160-9289            Impact factor:   2.882


  20 in total

1.  'Ally McBeal heart?'-- drug induced cardiomyopathy in a young woman.

Authors:  A M Crean; J E F Pohl
Journal:  Br J Clin Pharmacol       Date:  2004-11       Impact factor: 4.335

2.  Reversible cardiomyopathy complicating intrathecal baclofen withdrawal: a case report.

Authors:  Anthony F Pizon; Frank Lovecchio
Journal:  J Med Toxicol       Date:  2007-12

3.  Drugs and dilated cardiomyopathies: A case/noncase study in the French PharmacoVigilance Database.

Authors:  Guillaume Montastruc; Sylvie Favreliere; Agnès Sommet; Atul Pathak; Maryse Lapeyre-Mestre; Marie-Christine Perault-Pochat; Jean-Louis Montastruc
Journal:  Br J Clin Pharmacol       Date:  2010-03       Impact factor: 4.335

4.  Recovery of methamphetamine associated cardiomyopathy predicted by late gadolinium enhanced cardiovascular magnetic resonance.

Authors:  Javier E Lopez; Khung Yeo; Gary Caputo; Michael Buonocore; Saul Schaefer
Journal:  J Cardiovasc Magn Reson       Date:  2009-11-11       Impact factor: 5.364

5.  False negative result for amphetamines on the Triage Drug of Abuse panel? The cause of the unusual phenomenon with experimental analyses.

Authors:  Wakako Hikiji; Keiko Kudo; Shinji Sato; Yosuke Usumoto; Akiko Tsuji; Noriaki Ikeda
Journal:  Int J Legal Med       Date:  2008-12-02       Impact factor: 2.686

6.  Acute methamphetamine exposure inhibits cardiac contractile function.

Authors:  Subat Turdi; Robbie M Schamber; Nathan D Roe; Herbert G Chew; Bruce Culver; Jun Ren
Journal:  Toxicol Lett       Date:  2009-05-27       Impact factor: 4.372

Review 7.  Methamphetamine-associated cardiomyopathy.

Authors:  Sekon Won; Robert A Hong; Ralph V Shohet; Todd B Seto; Nisha I Parikh
Journal:  Clin Cardiol       Date:  2013-08-27       Impact factor: 2.882

8.  A comparison of echocardiographic findings in young adults with cardiomyopathy: with and without a history of methamphetamine abuse.

Authors:  Hiroki Ito; Khung-Keong Yeo; Mevan Wijetunga; Todd B Seto; Kevin Tay; Irwin J Schatz
Journal:  Clin Cardiol       Date:  2009-06       Impact factor: 2.882

9.  The Combined Human Genotype of Truncating TTN and RBM20 Mutations Is Associated with Severe and Early Onset of Dilated Cardiomyopathy.

Authors:  Anna Gaertner; Julia Bloebaum; Andreas Brodehl; Baerbel Klauke; Katharina Sielemann; Astrid Kassner; Henrik Fox; Michiel Morshuis; Jens Tiesmeier; Uwe Schulz; Ralph Knoell; Jan Gummert; Hendrik Milting
Journal:  Genes (Basel)       Date:  2021-06-08       Impact factor: 4.096

10.  Clinical and echocardiographic outcomes in heart failure associated with methamphetamine use and cessation.

Authors:  Harpreet Singh Bhatia; Marin Nishimura; Stephen Dickson; Eric Adler; Barry Greenberg; Isac C Thomas
Journal:  Heart       Date:  2020-10-05       Impact factor: 5.994
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.